ARCHIVES

Efaproxyn Improved Survival Of Patients With Brain Mets

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Local University Competing for Part FCRF Contract

December 4, 1981

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

October 15, 1976

Howard Hughes Medical Institute Seeks up to 25 New Researchers

January 17, 2014